4//SEC Filing
Jaksch Frank L Jr 4
Accession 0001628280-25-033057
CIK 0001386570other
Filed
Jun 24, 8:00 PM ET
Accepted
Jun 25, 8:23 PM ET
Size
5.5 KB
Accession
0001628280-25-033057
Insider Transaction Report
Form 4
Jaksch Frank L Jr
DirectorCEO10% Owner
Transactions
- Award
Stock Option (right to buy)
2025-06-24+20,000→ 20,000 totalExercise: $14.13From: 2026-06-24Exp: 2035-06-23→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]Option vests 100% on June 24, 2026.
Documents
Issuer
Niagen Bioscience, Inc.
CIK 0001386570
Entity typeother
Related Parties
1- filerCIK 0001437237
Filing Metadata
- Form type
- 4
- Filed
- Jun 24, 8:00 PM ET
- Accepted
- Jun 25, 8:23 PM ET
- Size
- 5.5 KB